Regeneron Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

WBAG:REGN Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
28 Aug 24	Sell€5,718,320	Christopher Fenimore	Individual	5,280	€1,083.98
28 Aug 24	Sell€433,731	Christopher Fenimore	Individual	400	€1,084.34
08 Aug 24	Sell€5,166,275	Neil Stahl	Individual	5,197	€995.57
26 Feb 24	Sell€912,582	Joseph LaRosa	Individual	1,000	€912.58
22 Feb 24	Sell€894,592	Joseph LaRosa	Individual	1,000	€894.59
14 Feb 24	Sell€9,166,119	Daniel Van Plew	Individual	10,434	€887.34
09 Feb 24	Sell€4,348,875	Christopher Fenimore	Individual	4,919	€885.67
07 Feb 24	Sell€7,098,714	Neil Stahl	Individual	8,037	€885.72
07 Feb 24	Sell€882,930	Joseph LaRosa	Individual	1,000	€882.93
05 Feb 24	Sell€871,430	Marion McCourt	Individual	1,000	€871.43

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of REGN?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	270	0.000251%
State or Government	119,091	0.111%
Individual Insiders	4,320,955	4.02%
General Public	7,905,319	7.35%
Institutions	95,243,896	88.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 64.71% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.28%	FMR LLC	9,989,118	€6.8b	-2.97%	0.42%
8.66%	The Vanguard Group, Inc.	9,320,290	€6.3b	3.63%	0.1%
7.96%	Capital Research and Management Company	8,562,198	€5.8b	-0.24%	0.29%
7.88%	BlackRock, Inc.	8,480,262	€5.8b	0.4%	0.1%
5.97%	JP Morgan Asset Management	6,427,659	€4.4b	-10.1%	0.52%
4.56%	State Street Global Advisors, Inc.	4,902,404	€3.3b	1.27%	0.13%
2.23%	Leonard Schleifer	2,395,911	€1.6b	0%	no data
2.15%	Dodge & Cox	2,311,935	€1.6b	-0.16%	0.57%
2.11%	Geode Capital Management, LLC	2,272,261	€1.5b	-5.92%	0.11%
1.33%	Putnam LLC	1,432,757	€972.5m	-2.29%	0.98%
1.19%	T. Rowe Price Group, Inc.	1,275,303	€865.7m	36.7%	0.08%
1.1%	Loomis Sayles & Company, L.P.	1,181,352	€801.9m	-2.92%	1.01%
1.07%	George Yancopoulos	1,153,695	€783.1m	0%	no data
1.05%	Norges Bank Investment Management	1,126,948	€765.0m	0%	0.07%
1%	Amundi Asset Management SAS	1,079,023	€732.4m	1.18%	0.16%
0.95%	UBS Asset Management AG	1,026,962	€697.1m	-6.82%	0.07%
0.89%	Legal & General Investment Management Limited	959,127	€651.0m	-1.94%	0.12%
0.85%	Northern Trust Global Investments	918,645	€623.6m	-4.97%	0.1%
0.69%	American Century Investment Management Inc	738,495	€501.3m	-10.6%	0.25%
0.67%	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	722,045	€490.1m	-5.06%	0.13%
0.66%	BNY Asset Management	706,789	€479.8m	-17.4%	0.1%
0.63%	Charles Schwab Investment Management, Inc.	673,261	€457.0m	1.74%	0.08%
0.62%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	669,066	€454.2m	14.1%	0.12%
0.62%	Invesco Capital Management LLC	666,982	€452.7m	32.2%	0.19%
0.59%	Morgan Stanley, Investment Banking and Brokerage Investments	630,259	€427.8m	-22.1%	0.05%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 15:04
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Regeneron Pharmaceuticals, Inc. is covered by 69 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jasper Hellweg	Argus Research Company
Brian Skorney	Baird
Ishan Majumdar	Baptista Research